Changes in the hospitalization rate or staffed hospital bed supply are needed to avoid reaching concerning thresholds, a new study finds.
The FDA has now resolved the shortages of Novo Nordisk and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...
A Denver District Court has granted a Temporary Restraining Order (TRO) filed by MedRide, allowing MedRide to resume ...
The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo massive ...
Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback